Skip to main navigation Skip to search Skip to main content

The antidiabetic drug rosiglitazone blocks Kv1.5 potassium channels in an open state

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
JournalTHE KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
StatePublished - 2022.03.1

Cite this